You are currently viewing a new version of our website. To view the old version click .

Proceedings, Volume 22, Issue 1

MMCS 2019 2019 - 117 articles

The 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery

Barcelona, Spain | 15–17 May 2019

Volume Editor:
Diego Muñoz-Torrero, University of Barcelona, Spain
F. Javier Luque, University of Barcelona, Spain

Cover Story: This issue of Proceedings gathers papers presented at 2nd MMCS (Barcelona, Spain, 15-17 May 2019). Encouraged by the great success of the initial small-format monographic MMCS2017, the three-day MMCS2019 grew naturally by addressing a larger audience and essentially all topics of medicinal chemistry. The MMCS2019 was organized into a number of thematic sessions on medicinal chemistry of particularly challenging diseases, novel and revisited drug discovery approaches, and medicinal chemistry stories about recently implemented projects in any area not covered in the other sessions, from target and hit identification to hit-to-lead optimization, tuning of physicochemical and pharmacokinetic properties, preclinical and clinical development, etc.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (117)

  • Abstract
  • Open Access
1,775 Views
1 Page

Bivalent degrader molecules (also termed PROTACs) target proteins for degradation through recruitment to E3 ligases. PROTACs are a revolutionary new modality class with therapeutic potential. Formation of a ternary complex between the degrader, the l...

  • Abstract
  • Open Access
1,075 Views
1 Page

Phospholipid-hydrolyzing enzymes, such as phospholipases A2 (PLA2s) and autotaxin (ATX), have attracted medicinal interest because they are involved in the generation of various inflammatory mediators. PLA2s hydrolyze membrane phospholipids initiatin...

  • Abstract
  • Open Access
1,207 Views
1 Page

2D-QSAR Studies of Dopamine Transporter Inhibitors (DAT) Using OPS and GA Variable Selection Approaches

  • Eduardo Borges de Melo,
  • Aline Thais Bruni and
  • João Paulo Ataide Martins

Today, drug abuse has developed into a social problem and begun to demand specific measures from different social sectors and government agencies all over the world. Despite significant efforts made toward relevant mechanistic targets, such as the do...

  • Extended Abstract
  • Open Access
1,272 Views
2 Pages

Enzymes are increasingly used as biocatalysts for the production of Active Pharmaceutical [...]

of 12

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Proceedings - ISSN 2504-3900